Distribution of lymph node metastasis including micrometastasis in gastric cancer with submucosal invasion

被引:45
作者
Higashi, H [1 ]
Natsugoe, S [1 ]
Ishigami, S [1 ]
Uenosono, Y [1 ]
Matsumoto, M [1 ]
Nakajo, A [1 ]
Miyazono, F [1 ]
Hokita, S [1 ]
Takao, S [1 ]
Aikou, T [1 ]
机构
[1] Kagoshima Univ, Sch Med, Dept Surg 1, Kagoshima 8908520, Japan
关键词
D O I
10.1007/s00268-002-6601-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
The purpose of this retrospective study was to analyze the distribution of lymph node metastases, including micrometastases, according to the location of the gastric cancer with submucosal invasion. A total of 118 patients with submucosal gastric cancer were enrolled in this study. The distribution of lymph node metastases was examined according to tumor location. Immunohistochemical examination using anti-cytokeratin antibody was performed to examine nodal micrometastases in 118 patients. Lymph node metastasis was found in 19.5% (23/118) of the patients. Significant differences were found for tumor size and depth, lymphatic invasion, and venous invasion for patients with and without nodal metastasis. The distribution of lymph node metastasis for tumors at upper or middle portions of the stomach was mainly found along the left gastric artery. The distribution of lymph node metastasis for tumors in the lower and lesser curvature varied. Immunohistochemical analysis found that 15 of 23 patients with lymph node metastasis found by histologic examination had micrometastases. The presence of two or more lymph node micrometastases was found in these 15 patients, and they were distributed in another stations, including distant nodes. The incidence of micrometastasis was 24.2% (23/95) in pN0 patients. Lymph node micrometastases were confined to regional nodes near the primary tumor. When planning minimally invasive treatment for submucosal gastric cancer, it is important to understand the distribution of lymph node metastasis, including micrometastasis, according to tumor location.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 30 条
[1]   Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[2]   Prognostic significance of occult lymph node metastases in node-negative breast cancer [J].
Clare, SE ;
Sener, SF ;
Wilkens, W ;
Goldschmidt, R ;
Merkel, D ;
Winchester, DJ .
ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (06) :447-451
[3]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[4]   RESTAGING OF COLORECTAL-CANCER BASED ON THE IDENTIFICATION OF LYMPH-NODE MICROMETASTASES THROUGH IMMUNOPEROXIDASE STAINING OF CEA AND CYTOKERATINS [J].
CUTAIT, R ;
ALVES, VAF ;
LOPES, LC ;
CUTAIT, DE ;
BORGES, JL ;
SINGER, J ;
DASILVA, JH ;
GOFFI, FS .
DISEASES OF THE COLON & RECTUM, 1991, 34 (10) :917-920
[5]   LYMPHATIC MAPPING AND SENTINEL LYMPHADENECTOMY FOR BREAST-CANCER [J].
GIULIANO, AE ;
KIRGAN, DM ;
GUENTHER, JM ;
MORTON, DL .
ANNALS OF SURGERY, 1994, 220 (03) :391-401
[6]  
Glickman JN, 1999, CANCER, V85, P769, DOI 10.1002/(SICI)1097-0142(19990215)85:4<769::AID-CNCR3>3.0.CO
[7]  
2-I
[8]  
GREENSON JK, 1994, CANCER-AM CANCER SOC, V73, P563, DOI 10.1002/1097-0142(19940201)73:3<563::AID-CNCR2820730311>3.0.CO
[9]  
2-D
[10]  
Harrison LE, 2000, J SURG ONCOL, V73, P153, DOI 10.1002/(SICI)1096-9098(200003)73:3<153::AID-JSO8>3.0.CO